Nectar Lifesciences Limited (NSE:NECLIFE)
India · Delayed Price · Currency is INR 10.42
+0.17 (1.66%)
Nov 11, 2026, 1:53 PM IST
Nectar Lifesciences Market Cap
Nectar Lifesciences has a market cap or net worth of 2.02 billion as of November 10, 2026. It is the 36,337th most valuable company in the world and the 2,729th biggest in India. Its market cap has decreased by 39.38% in one year.
Market Cap
2.02B
Enterprise Value
773.14M
Revenue
145.00K
Global Rank
Country Rank
#2,729 India
PE Ratio
n/a
ChartMarket Cap Chart
Since July 18, 2005, Nectar Lifesciences's market cap has decreased from 2.87B to 2.02B, a decrease of -29.36%. That is a compound annual growth rate of -1.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 2.02B | -53.50% |
| Dec 31, 2025 | 4.35B | -50.21% |
| Dec 31, 2024 | 8.74B | 21.24% |
| Dec 29, 2023 | 7.21B | 30.96% |
| Dec 30, 2022 | 5.51B | -8.40% |
| Dec 31, 2021 | 6.01B | 12.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anlon Healthcare | 14.31B |
| Bafna Pharmaceuticals | 11.18B |
| Sigachi Industries | 10.37B |
| Amanta Healthcare | 7.85B |
| Valiant Laboratories | 6.06B |
| Brooks Laboratories | 1.94B |
| Par Drugs and Chemicals | 1.39B |
| Balaxi Pharmaceuticals | 1.25B |